Judge Approves Settlement In Stock Drop Suit Against Biopharmaceutical Company
SAN JOSE, Calif. — A federal judge in California granted final approval to a $7.25 million settlement in a case brought by investors against a biopharmaceutical company, certain of its executives...To view the full article, register now.
Already a subscriber? Click here to view full article